What is the recommended dosing frequency for intramuscular administration of Rocephin (ceftriaxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rocephin (Ceftriaxone) IM Dosing Frequency

For intramuscular administration of Rocephin (ceftriaxone), the frequency is once daily (every 24 hours) for most indications in both adults and children.

Adult Dosing

The standard IM dosing for adults is 1-2 grams once daily, depending on infection severity 1. The total daily dose should not exceed 4 grams. For uncomplicated gonococcal infections specifically, a single 250 mg IM dose is recommended 1.

Pediatric Dosing

Neonates (≤28 days)

  • 50-75 mg/kg once daily (every 24 hours) 2, 3
  • Dosing varies by postnatal age and weight:
    • ≤7 days: 50 mg/kg/day every 24 hours
    • 7 days and ≤2000 g: 50 mg/kg/day every 24 hours

    • 7 days and >2000 g: 50-75 mg/kg/day every 24 hours 2

Infants and Children (>28 days)

The frequency depends on the indication:

  • Skin/soft tissue infections: 50-75 mg/kg once daily (or divided every 12 hours), max 2 g/day 1
  • Acute otitis media: Single IM dose of 50 mg/kg (max 1 gram) 1
  • Serious infections (non-meningitis): 50-75 mg/kg divided every 12 hours, max 2 g/day 1
  • Meningitis: 100 mg/kg/day given once daily or divided every 12 hours, max 4 g/day 1
  • UTI/bacteremia (22-60 days old): 50 mg/kg once daily (every 24 hours) 3

Key Clinical Considerations

The once-daily dosing advantage is supported by ceftriaxone's exceptionally long elimination half-life of 5.8-8.7 hours 4, which allows for sustained therapeutic concentrations with single daily administration. This pharmacokinetic profile makes it ideal for outpatient parenteral therapy 5, 6.

Important caveats:

  • For meningitis in children, recent pharmacokinetic data suggests once-daily dosing (100 mg/kg) achieves superior CSF penetration compared to twice-daily dosing (50 mg/kg every 12 hours), with 88% vs 53% probability of target attainment at 24 hours 7
  • Patients with augmented renal clearance (eGFR >60 mL/min/1.73 m²) may require twice-daily dosing (1 g every 12 hours) to maintain adequate drug levels 8
  • In neonates receiving IV administration, infuse over 60 minutes to reduce bilirubin encephalopathy risk 1

The standard approach is once-daily IM administration for most infections, with twice-daily dosing reserved for serious pediatric infections (excluding meningitis) or patients with preserved/augmented renal function.

Related Questions

Can you explain ceftriaxone (Cetrikast), including its dosage, administration route, side effects, and precautions?
What is the recommended ceftriaxone dosage for pediatric patients, including neonates (≤28 days) and children older than 28 days?
What is the recommended ceftriaxone dosing regimen for an adult with community‑acquired pneumonia, including adjustments for disease severity and renal impairment?
How can I convert a pediatric ceftriaxone regimen of 50 mg/kg every 12 hours to a once‑daily dose of 100 mg/kg?
For how many days should a patient with a creatinine clearance of 185.8 mL/min be treated with 2 g ceftriaxone (Rocephin) intravenously?
What is the clotting cascade, including the extrinsic, intrinsic, and common pathways?
In a patient with poorly differentiated esophageal squamous cell carcinoma, is concurrent chemoradiotherapy over approximately six weeks preferable to sequential chemotherapy followed by radiotherapy over six months in terms of tumor control, risk of esophageal stricture requiring nasogastric (Ryle’s) tube feeding, and overall prognosis, and what is the evidence regarding the safety and efficacy of lemongrass (Cymbopogon) tea as an antioxidant during treatment?
What are the causes of palpitations accompanied by increased sweating?
What is the appropriate evaluation and management of hypernatremia with elevated serum osmolality?
In a patient with an elevated thyroid‑stimulating hormone (TSH) level and normal triiodothyronine (T3) and thyroxine (T4) who reports sweating, palpitations, and heat intolerance, what is the most likely cause?
Should a patient continue a direct‑acting oral anticoagulant (DOAC) after transcatheter aortic valve implantation (TAVI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.